Enzo Biochem, Inc. (ENZ) Misses Q1 Views
Enzo Biochem, Inc. (NYSE: ENZ) reported Q1 EPS of ($0.12), $0.04 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $25.75 million versus the consensus estimate of $27.04 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Enzo Biochem Added To Russell 2000, Russell 3000 and Russell Global Indexes
- Methode Electronics (MEI) Tops Q4 EPS by 7c; Guides FY17 Modestly Below the Street
- Cyanotech Corp (CYAN) Reports Q4 Loss of $0.73/Share
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!